About this trial
Ectopic pregnancy prevalence is approximately 1-2% of all pregnancies, majority of which located in the fallopian tube. Among the risk factors for ectopic pregnancy is tubal factor - meaning a mechanical problem within the fallopian tube resulting in the pregnancy remaining in the fallopian tube. The treatment o tubal pregnancy can be expectant, medical via metotrexate or surgicl via laparoscopic salpingectomy of the involved fallopian tube. The purpose of this study is to assess the feasibility of chromotubation during laparoscopic salpingectomy for the surgical management of tubal ectopic pregnancy hence assessing the function of the remaining fallopian tube and trying to predict future fertility for the patient.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with a history of unilateral salpingectomy
Patients with suspected heterotopic pregnancy
Patients with suspected allergic reaction to blue dye injection
Trial design
Treatments tested in this trial
- performing chromotubation during the laparoscopy in order to assess the tubal patency of the remaining fallopian tube